Carlos Solorzano-De
Pamplona, NC 31008, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
A Lightweight, 3D-Printable, Low-Cost, "One-Click" Dorsal Skin Window for High-Quality Long-Term Multimodal Subcutaneous Tumor Imaging.
Journal: Advanced healthcare materials
Published: March 09, 2026
Tumor Organoids Grown in Mixed-Composition Hydrogels Recapitulate the Plasticity of Pancreatic Cancers.
Journal: Gels (Basel, Switzerland)
Published: June 30, 2025
Going hi-res in bulk: flowless multiangle dynamic light scattering for detection on asymmetric flow field flow fractionation.
Journal: Journal of materials chemistry. B
Published: May 23, 2025
Astrocytic GLUT1 reduction paradoxically improves central and peripheral glucose homeostasis.
Journal: Science advances
Published: October 18, 2024
Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities.
Journal: Journal for immunotherapy of cancer
Published: May 13, 2024
Immune Scenario Identification Combining Multiplexed, Quantitative, and Advanced Imaging Analysis Could Be Relevant in Immunotherapy against Glioblastoma and Grade 4 Astrocytoma.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: March 05, 2024
Multimodal evaluation of drug antibacterial activity reveals cinnamaldehyde analog anti-biofilm effects against Haemophilus influenzae.
Journal: Biofilm
Published: October 10, 2023
In vitro modeling of polyclonal infection dynamics within the human airways by Haemophilus influenzae differential fluorescent labeling.
Journal: Microbiology spectrum
Published: October 05, 2023
Automatic Segmentation and Quantification of Nigrosome-1 Neuromelanin and Iron in MRI: A Candidate Biomarker for Parkinson's Disease.
Journal: Journal of magnetic resonance imaging : JMRI
Published: June 26, 2023
Synplex: In Silico Modeling of the Tumor Microenvironment From Multiplex Images.
Journal: IEEE transactions on medical imaging
Published: May 08, 2023
Prussian Blue nanoparticles: An FDA-approved substance that may quickly degrade at physiological pH.
Prussian Blue nanoparticles: An FDA-approved substance that may quickly degrade at physiological pH.
Journal: Colloids and surfaces. B, Biointerfaces
Published: October 07, 2022
Last Updated: 09/26/2026